A012303: ShortStop-HER2 - Clinical Trial
Who Can Participate in the Study?
Age Group
Adults
Study Details
Full Title
Protocol A012303, ShortStop-HER2: Shortened duration of adjuvant therapy in patients with early-stage HER2+ breast cancer who achieve pCR after neoadjuvant chemotherapy with HER2 blockade.
Principal Investigator
Neha Verma, MD
Medical Oncologist
Protocol Number
IRB:
PRO00119313
NCT:
NCT06876714
Phase
Phase III
ClinicalTrials.gov
View on ClinicalTrials.gov
Enrollment Status
Open for Enrollment